Johns Hopkins biomedical engineers use federal funding to pioneer immunotherapies that could free diabetes patients from insulin dependence.

Biomedical engineer Joshua Doloff uses federal funding to pioneer immunotherapies that could free diabetes patients from insulin dependence ...

Johns Hopkins engineers are developing treatments for Type 1 diabetes that don't rely on daily insulin injections or wearing an insulin pump to manage ...